CSPC Innovation Pharmaceutical Co Ltd Class A Working Capital to Net Assets Ratio
CSPC Innovation Pharmaceutical Co Ltd Class A working capital to net assets ratio. CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a Working Capital to Net Assets ratio of -0.1% as of March 2026. Working capital of CN¥-2.04 Million (current assets of CN¥2.77 Billion minus current liabilities of CN¥2.77 Billion) is measured against net assets of CN¥2.67 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 300765 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)
Working capital to net assets ratio of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2025. This chart shows how CSPC Innovation Pharmaceutical Co Ltd Class A's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at -0.1%, reflecting working capital of CN¥-2.04 Million against net assets of CN¥2.67 Billion CNY. See how many days can CSPC Innovation Pharmaceutical Co Ltd Cl fund operations to measure how many days the company can operate on defensive assets alone.
CSPC Innovation Pharmaceutical Co Ltd Class A Working Capital to Net Assets Ratio by Year (2014–2025)
CSPC Innovation Pharmaceutical Co Ltd Class A working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CSPC Innovation Pharmaceutical Co Ltd Cl assets under control.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 5.2% | CN¥144.01 Million | CN¥2.80 Billion | CN¥2.85 Billion | CN¥2.71 Billion | ▼ -25.3 pp |
| 2024 | 30.4% | CN¥1.37 Billion | CN¥4.50 Billion | CN¥2.80 Billion | CN¥1.43 Billion | ▼ -19.1 pp |
| 2023 | 49.5% | CN¥2.71 Billion | CN¥5.48 Billion | CN¥4.62 Billion | CN¥1.90 Billion | ▼ -16.6 pp |
| 2022 | 66.1% | CN¥2.61 Billion | CN¥3.94 Billion | CN¥3.19 Billion | CN¥582.77 Million | ▲ +3.1 pp |
| 2021 | 63.0% | CN¥2.08 Billion | CN¥3.30 Billion | CN¥2.49 Billion | CN¥408.64 Million | ▲ +0.6 pp |
| 2020 | 62.5% | CN¥1.68 Billion | CN¥2.69 Billion | CN¥1.91 Billion | CN¥235.05 Million | ▼ -1.2 pp |
| 2019 | 63.6% | CN¥1.54 Billion | CN¥2.42 Billion | CN¥1.94 Billion | CN¥400.76 Million | ▲ +32.4 pp |
| 2018 | 31.2% | CN¥311.57 Million | CN¥999.35 Million | CN¥660.92 Million | CN¥349.35 Million | ▲ +6.2 pp |
| 2017 | 25.0% | CN¥191.73 Million | CN¥766.93 Million | CN¥466.32 Million | CN¥274.59 Million | ▲ +19.2 pp |
| 2016 | 5.8% | CN¥33.00 Million | CN¥572.02 Million | CN¥392.80 Million | CN¥359.80 Million | ▼ -56.3 pp |
| 2015 | 62.1% | CN¥389.06 Million | CN¥626.83 Million | CN¥561.79 Million | CN¥172.74 Million | ▲ +17.4 pp |
| 2014 | 44.7% | CN¥239.85 Million | CN¥537.16 Million | CN¥498.82 Million | CN¥258.97 Million | — |